Scinovex
article Open AccessTop 1% cited

Mortality in systemic lupus erythematosus

Arthritis & Rheumatism · 2006 · Vol. 54(8) · pp. 2550–2557
Sasha BernatskyJ.‐F. BoivinL. JosephS ManziEllen M. GinzlerDafna D. GladmanMurray B. UrowitzPaul R. FortinMichelle PetriSusan G. BarrCaroline GordonSang‐Cheol BaeDavid IsenbergAsad ZomaCynthia AranowMary Anne DooleyOla NivedGunnar SturfeltK SteinssonGraciela S. AlarcónJean‐Luc SenécalMichel ZummerJG HanlyStephanie EnsworthJanet PopeSteven M. EdworthyAnisur RahmanJohn SibleyHani El‐GabalawyT McCarthyY. St. PierreAnn E. ClarkeRosalind Ramsey‐Goldman

Abstract

Our data from a very large multicenter international cohort emphasize what has been demonstrated previously in smaller samples. These results highlight the increased mortality rate in SLE patients compared with the general population, and they suggest particular risk associated with female sex, younger age, shorter SLE duration, and black/African American race. The risk for certain types of deaths, primarily related to lupus activity (such as renal disease), has decreased over time, while the risk for deaths due to circulatory disease does not appear to have diminished.

Systemic Lupus Erythematosus ResearchAtherosclerosis and Cardiovascular DiseasesSystemic Sclerosis and Related DiseasesMedicineStandardized mortality ratioCohortMortality ratePopulationConfidence intervalSystemic lupus erythematosusCohort studyInternal medicineEpidemiology

MeSH terms

AdolescentAdultCause of DeathFemaleUnited KingdomHumansIcelandInternational CooperationKoreaLupus Erythematosus, SystemicMaleMiddle AgedNorth AmericaRegistriesSweden

Funding

  • Arthritis Foundation
  • Lupus Research Alliance
  • Lupus Canada
  • Arthritis Society
  • University of Toronto
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • Medical Research Council
  • National Cancer Institute
  • Canadian Arthritis Network
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.